Business
    Next Score View the next score

    mass. movers

    Infinity Pharmaceuticals stock slides

    One Infinity cancer drug under development targets patients who smoked heavily.
    Associated Press
    One Infinity cancer drug under development targets patients who smoked heavily.
    Advertisement

    Leukemia-drug competitors of Infinity Pharmaceuticals Inc., The Wall Street Journal reported, had strong if incremental releases of scientific data about their products Wednesday. But JPMorgan says investors are “increasingly skittish” ahead of June’s American Society of Clinical Oncology conference, at which Infinity is expected to release safety and tolerability data for its drug. The bank predicts “a good showing” by Infinity but warns it may not be enough to outshine the rivals.